325 related articles for article (PubMed ID: 22634691)
1. Therapeutic strategies in post-facial paralysis synkinesis in adult patients.
Terzis JK; Karypidis D
Plast Reconstr Surg; 2012 Jun; 129(6):925e-939e. PubMed ID: 22634691
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients.
Terzis JK; Karypidis D
J Plast Reconstr Aesthet Surg; 2012 Aug; 65(8):1009-18. PubMed ID: 22483723
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Changes in the Treatment Pattern of Botulinum Toxin A Injections for Postfacial Paralysis Synkinesis Following Modified Selective Neurectomy.
Hjelm N; Crippen M; Azizzadeh B
Facial Plast Surg Aesthet Med; 2021; 23(3):234-235. PubMed ID: 33306003
[No Abstract] [Full Text] [Related]
4. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
[TBL] [Abstract][Full Text] [Related]
5. Modified Selective Neurectomy for the Treatment of Post-Facial Paralysis Synkinesis.
Azizzadeh B; Irvine LE; Diels J; Slattery WH; Massry GG; Larian B; Riedler KL; Peng GL
Plast Reconstr Surg; 2019 May; 143(5):1483-1496. PubMed ID: 30807497
[TBL] [Abstract][Full Text] [Related]
6. Management of synkinesis.
Husseman J; Mehta RP
Facial Plast Surg; 2008 May; 24(2):242-9. PubMed ID: 18470836
[TBL] [Abstract][Full Text] [Related]
7. Platysma synkinesis in facial palsy and botulinum toxin type A.
Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
[TBL] [Abstract][Full Text] [Related]
8. Epidemiologic Overview of Synkinesis in 353 Patients with Longstanding Facial Paralysis under Treatment with Botulinum Toxin for 11 Years.
Salles AG; da Costa EF; Ferreira MC; do Nascimento Remigio AF; Moraes LB; Gemperli R
Plast Reconstr Surg; 2015 Dec; 136(6):1289-1298. PubMed ID: 26595022
[TBL] [Abstract][Full Text] [Related]
9. Facial synkinesis: A distressing sequela of facial palsy.
Shokri T; Patel S; Ziai K; Harounian J; Lighthall JG
Ear Nose Throat J; 2024 Jun; 103(6):NP382-NP391. PubMed ID: 34836457
[TBL] [Abstract][Full Text] [Related]
10. Quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A.
Cecini M; Pavese C; Comelli M; Carlisi E; Sala V; Bejor M; Toffola ED
Plast Reconstr Surg; 2013 Nov; 132(5):1255-1264. PubMed ID: 24165606
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
[TBL] [Abstract][Full Text] [Related]
12. Individualized management of facial synkinesis based on facial function.
Maria CM; Kim J
Acta Otolaryngol; 2017 Sep; 137(9):1010-1015. PubMed ID: 28471705
[TBL] [Abstract][Full Text] [Related]
13. An objective assessment of botulinum toxin type A injection in the treatment of post-facial palsy synkinesis and hyperkinesis using the synkinesis assessment questionnaire.
Neville C; Venables V; Aslet M; Nduka C; Kannan R
J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1624-1628. PubMed ID: 28688864
[TBL] [Abstract][Full Text] [Related]
14. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target.
Wei LA; Diels J; Lucarelli MJ
Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382
[TBL] [Abstract][Full Text] [Related]
15. Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.
Shinn JR; Nwabueze NN; Du L; Patel PN; Motamedi KK; Norton C; Ries WR; Stephan SJ
JAMA Facial Plast Surg; 2019 May; 21(3):244-251. PubMed ID: 30703206
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular retraining therapy combined with preceding botulinum toxin A injection for chronic facial paralysis.
Jeong J; Lee JM; Kim J
Acta Otolaryngol; 2023 May; 143(5):446-451. PubMed ID: 37173287
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.
McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R
Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis.
Filipo R; Spahiu I; Covelli E; Nicastri M; Bertoli GA
Laryngoscope; 2012 Feb; 122(2):266-70. PubMed ID: 22252570
[TBL] [Abstract][Full Text] [Related]
20. Repair of ocular-oral synkinesis of postfacial paralysis using cross-facial nerve grafting.
Zhang B; Yang C; Wang W; Li W
J Reconstr Microsurg; 2010 Aug; 26(6):375-80. PubMed ID: 20221986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
